Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | EVP, Chief Comm. Officer | June 06, 2025 | June 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date June 06, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,133 |
Ending reported balance
After 2025-06-06 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-06-06 · Exercise / conversion · Acquired 20,000 · Balance 83,133 Row 2 · 2025-06-06 · Sale · Disposed 12,296 · Balance 70,837 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Row 3 · 2025-06-06 · Sale · Disposed 5,904 · Balance 64,933 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Row 4 · 2025-06-06 · Sale · Disposed 1,800 · Balance 63,133 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.18 · Expires 2030-12-15 | Direct | 11,578 |
Reported balance
After 2025-06-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-06-06 · Exercise / conversion · Disposed 20,000 · Balance 11,578 F4: The stock option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4: The stock option is fully vested and exercisable.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 1
1 source rowRow 1 · 2018-10-23 · Disposition to issuer · Disposed 25,000 · Balance 0 F1: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F2: The RSUs were cancelled pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018, in exchange for an amount in cash per underlying share equal to $7.40 per share, without interest, subject to any required withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F2: The RSUs were cancelled pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018, in exchange for an amount in cash per underlying share equal to $7.40 per share, without interest, subject to any required withholding of taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2025 Filed Jun 6, 2025 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · derivative · entry 5 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,578 Underlying: Common Stock · 20,000 shares Expires 2030-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 1,800 | $65.35 | $117,631.08 |
DisclosureSEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 4 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,133 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.29 to $65.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 5,904 | $64.64 | $381,609.76 |
DisclosureSEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 3 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,933 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.24 to $65.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 12,296 | $63.71 | $783,396.60 |
DisclosureSEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,837 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.24 to $64.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 20,000 | $5.18 | $103,600.00 |
DisclosureSEC source: 0001628280-25-029968 · wk-form4_1749240151.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:08 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 247 | $57.06 | $14,093.82 |
DisclosureSEC source: 0001628280-25-013817 · wk-form4_1742414903.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,133 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:29 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,588 | $61.31 | $219,980.28 |
DisclosureSEC source: 0001628280-25-011707 · wk-form4_1741638582.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,380 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:34 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 9,810 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010616 · wk-form4_1741214062.xml · derivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,810 Underlying: Common Stock · 9,810 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:34 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 11,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010616 · wk-form4_1741214062.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,968 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 22:44 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,046 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001628280-24-027911 · wk-form4_1718232237.xml · derivative · entry 3 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,450 Underlying: Common Stock · 26,046 shares Expires 2029-04-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/9/2024. F2 · derivative.exercise_date: The Stock option was granted on April 5, 2019 and vested 10/46th on the ten month anniversary of the vesting commencement date of March 25, 2019 and the remaining vested monthly over a three year period thereafter. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 22:44 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 26,046 | $68.24 | $1,777,498.85 |
DisclosureSEC source: 0001628280-24-027911 · wk-form4_1718232237.xml · nonDerivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,860 F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/9/2024. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 22:44 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 26,046 | $4.56 | $118,769.76 |
DisclosureSEC source: 0001628280-24-027911 · wk-form4_1718232237.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/9/2024. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:41 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 244 | $48.83 | $11,914.52 |
DisclosureSEC source: 0001628280-24-012235 · wk-form4_1710967284.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,860 F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:50 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 23,038 | $0.00 Strike: $47.17 | $0.00 |
DisclosureSEC source: 0001628280-24-009762 · wk-form4_1709859012.xml · derivative · entry 3 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,038 Underlying: Common Stock · 23,038 shares Expires 2034-03-05 F4 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:50 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 1,759 | $46.67 | $82,092.53 |
DisclosureSEC source: 0001628280-24-009762 · wk-form4_1709859012.xml · nonDerivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,104 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on February 16, 2023. F3 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:50 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 26,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009762 · wk-form4_1709859012.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,863 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| April 11, 2023 Filed Apr 12, 2023 20:15 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 21,930 | $35.23 | $772,514.95 |
DisclosureSEC source: 0001628280-23-011393 · wf-form4_168133054598278.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,414 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35 to $35.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 19:52 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 246 | $31.84 | $7,832.64 |
DisclosureSEC source: 0001628280-23-008455 · wf-form4_167908276738385.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,344 F1 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:33 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 47,732 | $0.00 Strike: $37.02 | $0.00 |
DisclosureSEC source: 0001628280-23-004321 · wf-form4_167701517373269.xml · derivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,732 Underlying: Common Stock · 47,732 shares Expires 2033-02-15 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2023 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:33 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 26,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-004321 · wf-form4_167701517373269.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,590 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2023, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 21:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 466 | $39.74 | $18,521.03 |
DisclosureSEC source: 0001628280-23-000454 · wf-form4_167295293970419.xml · nonDerivative · entry 4 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,275 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $40.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 6,306 | $41.74 | $263,210.55 |
DisclosureSEC source: 0001628280-23-000454 · wf-form4_167295293970419.xml · nonDerivative · entry 3 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,741 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.35 to $42.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 5,421 | $40.47 | $219,380.82 |
DisclosureSEC source: 0001628280-23-000454 · wf-form4_167295293970419.xml · nonDerivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,047 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.04 to $41.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:09 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 9,736 | $39.76 | $387,097.52 |
DisclosureSEC source: 0001628280-23-000454 · wf-form4_167295293970419.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,468 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 9, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 931 shares acquired on May 13, 2022 and 500 shares acquired on November 14, 2022 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 7,924 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001628280-22-008262 · wf-form4_164910702875581.xml · derivative · entry 2 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,924 Underlying: Common Stock · 7,924 shares Expires 2032-03-30 F2 · price: The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date. F2 · derivative.exercise_date: The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 3,914 | $29.38 | $114,993.32 |
DisclosureSEC source: 0001628280-22-008262 · wf-form4_164910702875581.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · EVP, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,773 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 15, 2023, with one-quarter of the remaining RSUs vesting annually on each of the second, third, and fourth anniversary thereof, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| October 23, 2018 Filed Oct 23, 2018 17:43 UTC | Invuity, Inc. IVTY · Entity 162847 | Disposition to issuerCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055988 · doc4.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · VP of Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F2 · price: The RSUs were cancelled pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018, in exchange for an amount in cash per underlying share equal to $7.40 per share, without interest, subject to any required withholding of taxes. Read SEC document |
| May 07, 2018 Filed May 9, 2018 21:33 UTC | Invuity, Inc. IVTY · Entity 162847 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-031873 · a4.xml · nonDerivative · entry 1 Shiblaq Hisham · CIK 0001739363 · VP of Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · shares: The restricted stock units vest as to one-fourth of the shares on May 7, 2019 and on each one year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.